Novel selective β <sub>1</sub> ‐adrenoceptor antagonists for concomitant cardiovascular and respiratory diseaseJillian G. Baker, Peter M. Fischer, Barrie Kellam et al.|The FASEB Journal|2017Cited by 20
Using Esterase Selectivity to Determine the <i>In Vivo</i> Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-BlockersJillian G. Baker, Peter M. Fischer, Christophe Fromont et al.|ACS Pharmacology & Translational Science|2020Cited by 4